Benign prostatic hyperplasia

Overview of attention for article published in Revista da Associação Médica Brasileira, October 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy: 1 policy source

Readers on

mendeley: 40 Mendeley

Summary Policy documents

So far, Altmetric has seen 2 policy documents that reference this research output.

Minimally invasive therapies for benign prostatic hyperplasia (BPH)

Cited by Canadian Agency for Drugs and Technologies in Health on 13 Feb 2020

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Minimally-Invasive Treatments for Lower Urinary Tract Symptoms in People with Benign Prostatic Hyperplasia: A Review of Clinical Effectiveness

Cited by Canadian Agency for Drugs and Technologies in Health on 03 Sep 2019

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.